AAAAAA

   
Results: 1-11 |
Results: 11

Authors: HILL S HOLMES CL SHIELDS JG MCLEAN CS ENTWISLE C BLAKELEY D BOURSNELL MEG HICKLING JK
Citation: S. Hill et al., USE OF A DISABLED INFECTIOUS SINGLE-CYCLE (DISC) HERPES-SIMPLEX VIRUS(HSV) AS A VECTOR FOR THE INDUCTION OF IMMUNE-RESPONSES TO PRODUCTS OF HETEROLOGOUS GENES, Journal of leukocyte biology, 1998, pp. 14-14

Authors: BOURSNELL MEG ENTWISLE C ALI SA SIVASUBRAMANIAM SD REEDER S MCLEAN CS BLAKELEY DM SHIELDS JG INGLIS SC REES RC
Citation: Meg. Boursnell et al., DISABLED INFECTIOUS SINGLE-CYCLE (DISC) HERPES-SIMPLEX VIRUS AS A VECTOR FOR IMMUNOTHERAPY OF CANCER, Cancer gene therapy, 4(5), 1997, pp. 321-321

Authors: BOURSNELL MEG ENTWISLE C BLAKELEY D ROBERTS C DUNCAN IA CHISHOLM SE MARTIN GM JENNINGS R CHALLANAIN DN SOBEK I INGLIS SC MCLEAN CS
Citation: Meg. Boursnell et al., A GENETICALLY INACTIVATED HERPES-SIMPLEX VIRUS TYPE-2 (HSV-2) VACCINEPROVIDES EFFECTIVE PROTECTION AGAINST PRIMARY AND RECURRENT HSV-2 DISEASE, The Journal of infectious diseases, 175(1), 1997, pp. 16-25

Authors: BOURSNELL MEG RUTHERFORD E HICKLING JK ROLLINSON EA MUNRO AJ ROLLEY N MCLEAN CS BORYSIEWICZ LK VOUSDEN K INGLIS SC
Citation: Meg. Boursnell et al., CONSTRUCTION AND CHARACTERIZATION OF A RECOMBINANT VACCINIA WAS EXPRESSING HUMAN PAPILLOMAVIRUS PROTEINS FOR IMMUNOTHERAPY OF CERVICAL-CANCER, Vaccine, 14(16), 1996, pp. 1485-1494

Authors: MCLEAN CS NICHALLANAIN D DUNCAN I BOURSNELL MEG JENNINGS R INGLIS SC
Citation: Cs. Mclean et al., INDUCTION OF A PROTECTIVE IMMUNE-RESPONSE BY MUCOSAL VACCINATION WITHA DISC HSV-1 VACCINE, Vaccine, 14(10), 1996, pp. 987-992

Authors: HICKLING JK BOURSNELL MEG RUTHERFORD E ROLLINSON E MCLEAN CS STACEY S BORYSIEWICZ LK INGLIS SC
Citation: Jk. Hickling et al., CONSTRUCTION OF A RECOMBINANT VACCINIA VIRUS EXPRESSING HPV TYPES-16 AND TYPE-18, TYPE-EL AND TYPE-E7 FOR IMMUNOTHERAPY OF CERVICAL-CARCINOMA, Journal of cellular biochemistry, 1995, pp. 311-311

Authors: MCLEAN CS DUNCAN IA CHISHOLM SE BOLT SL BOURSNELL MEG INGLIS SC MINSON AC SHIELDS JG
Citation: Cs. Mclean et al., LONG-TERM PROTECTION FOLLOWING VACCINATION WITH A GH-DELETED HERPES-SIMPLEX VIRUS TYPE-1, Journal of cellular biochemistry, 1995, pp. 312-312

Authors: MCLEAN CS
Citation: Cs. Mclean, THE URANIUM INDUSTRY OF SOUTH-AFRICA, Journal of the South African Institute of Mining and Metallurgy, 94(3), 1994, pp. 113-122

Authors: FARRELL HE MCLEAN CS HARLEY C EFSTATHIOU S INGLIS S MINSON AC
Citation: He. Farrell et al., VACCINE POTENTIAL OF A HERPES-SIMPLEX VIRUS TYPE-1 MUTANT WITH AN ESSENTIAL GLYCOPROTEIN DELETED, Journal of virology, 68(2), 1994, pp. 927-932

Authors: MCLEAN CS ERTURK M JENNINGS R NICHALLANAIN D MINSON AC DUNCAN I BOURSNELL MEG INGLIS SC
Citation: Cs. Mclean et al., PROTECTIVE VACCINATION AGAINST PRIMARY AND RECURRENT DISEASE CAUSED BY HERPES-SIMPLEX VIRUS (HSV) TYPE-2 USING A GENETICALLY DISABLED HSV-1, The Journal of infectious diseases, 170(5), 1994, pp. 1100-1109

Authors: BROUSSARD JR MCLEAN CS
Citation: Jr. Broussard et Cs. Mclean, AN ALGORITHM FOR SIMULTANEOUS STABILIZATION USING DECENTRALIZED CONSTANT GAIN OUTPUT-FEEDBACK, IEEE transactions on automatic control, 38(3), 1993, pp. 450-455
Risultati: 1-11 |